Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy

2 years ago

SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering…

NASA Launches rHEALTH Blood Analyzer to International Space Station

2 years ago

BEDFORD, Mass., Feb. 22, 2022 /PRNewswire-PRWeb/ -- rHEALTH announced today that NASA has successfully launched its rHEALTH ONE blood analyzer to…

Health Catalyst Announces Intent to Acquire KPI Ninja

2 years ago

SALT LAKE CITY, Feb. 22, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics…

Shepherd Expands Veterinary Practice Management Software Automation Capabilities

2 years ago

PRESCOTT, Ariz., Feb. 22, 2022 /PRNewswire/ -- Shepherd Veterinary Software, founded by practicing veterinarian Cindy Barnes, DVM, CVSMT, announced today…

Medigate Selected by American Hospital Association as Preferred Cybersecurity Service Provider

2 years ago

BROOKLYN, N.Y., Feb. 22, 2022 /PRNewswire/ -- Medigate by Claroty, healthcare's leading clinical device data security and integration platform, today announced…

First Japanese Institution to Utilize SOPHiA GENETICS’ Myeloid Plus Solution

2 years ago

BOSTON, LAUSANNE, Switzerland, and HIROSHIMA, Japan, Feb. 22, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), today announced an agreement with…

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2022

2 years ago

WARSAW, Ind., Feb. 22, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today…

Geltor Completes First Full-Scale Commercial Manufacturing Run of PrimaColl® for Food and Beverage

2 years ago

SAN LEANDRO, Calif., Feb. 22, 2022 /PRNewswire/ -- Geltor today announced the successful completion of its commercial-scale manufacturing run of PrimaColl®,…

AOBiome Therapeutics’ topical biotherapeutic B244 demonstrated positive Phase 2b results from its 547 patient trial for both Pruritus (Itch) and Appearance in its 547 patient Phase 2b trial of Atopic Dermatitis (Eczema)

2 years ago

CAMBRIDGE, Mass., Feb. 22, 2022 /PRNewswire/ -- AOBiome Therapeutics, a clinical stage biotechnology company focused on transforming human health by developing…

Digital Health Market Size Worth $295.4 Billion By 2028 | CAGR: 15.1%: Grand View Research, Inc.

2 years ago

SAN FRANCISCO, Feb. 22, 2022 /PRNewswire/ -- The global digital health market size is expected to reach USD 295.4 billion…